Fractyl Health, Inc.
Fractyl Health, Inc., headquartered in the United States, is a pioneering company in the healthcare industry, focusing on innovative solutions for metabolic diseases. Founded in 2010, Fractyl has made significant strides in developing therapies that address the underlying causes of type 2 diabetes and obesity, setting itself apart with its unique approach to metabolic health. The company’s flagship product, the Revita procedure, is a minimally invasive treatment designed to improve metabolic function and promote weight loss. This groundbreaking service has positioned Fractyl as a leader in the metabolic health sector, with a commitment to transforming patient outcomes through advanced medical technology. With a strong presence in major operational regions across the US, Fractyl Health continues to drive progress in metabolic disease management, earning recognition for its innovative contributions to the field.
DitchCarbon Score
How does Fractyl Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fractyl Health, Inc.'s score of 18 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fractyl Health, Inc.'s reported carbon emissions
Fractyl Health, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As such, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of concrete emissions data, it is important to note that Fractyl Health has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon neutrality, Fractyl Health's future initiatives may align with broader trends in the healthcare sector, which is focusing on reducing its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fractyl Health, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
